In a significant shift for the US pharmaceutical landscape, President Donald Trump has formally announced in May 2025, a push ...

Washington, USA-based immunotherapy specialist Adaptive Biotechnologies (Nasdaq: ADPT) said Monday that its strategic ...

Shanghai Henlius Biotech today revealed it has entered into a strategic collaboration with fellow Chinese drug developer ...

Shares of San Diego, USA-based Viking Therapeutics tumbled 43% to $23.50 by mid-morning after the company released mid-stage ...

Heidelberg, Germany-based research institute BioMed X announced a new collaboration with Denmark’s Novo Nordisk, which aims ...

Privately-held US biotech Skyhawk Therapeutics has announced a strategic research collaboration with Germany’s Merck KGaA ...

Clinical research provider IQVIA and Veeva System have announced global clinical and commercial partnerships and the complete ...

Australian biotech CSL Limited today reported net profit after tax of US$3.0 billion for the 12 months ended June 30, 2025, ...

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Vanda Pharmaceuticals (Nasdaq: VNDA) secured a sweeping victory in its legal battle with the US regulator after the Court of Appeals for the District of Columbia Circuit overturned the agency’s ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...

I-novion is a privately-owned biotech company that offers proprietary formulation-based solutions to greatly prolong the duration of drug release. The US-based company holds exclusive worldwide rights ...